Cargando…
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Chemotherapy with anthracycline-based regimens remains a cornerstone of treatment of many solid and blood tumors but is associated with a significant risk of cardiotoxicity, which can manifest as asymptomatic left ventricular dysfunction or overt heart failure. These effects are typically dose-depen...
Autores principales: | Fabiani, Iacopo, Aimo, Alberto, Grigoratos, Chrysanthos, Castiglione, Vincenzo, Gentile, Francesco, Saccaro, Luigi F, Arzilli, Chiara, Cardinale, Daniela, Passino, Claudio, Emdin, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149360/ https://www.ncbi.nlm.nih.gov/pubmed/33319255 http://dx.doi.org/10.1007/s10741-020-10063-9 |
Ejemplares similares
-
Biomarkers for the diagnosis and management of heart failure
por: Castiglione, Vincenzo, et al.
Publicado: (2021) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Subclinical cardiac damage in cancer patients before chemotherapy
por: Fabiani, Iacopo, et al.
Publicado: (2021) -
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
por: Chianca, Michela, et al.
Publicado: (2022) -
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease
por: Aimo, Alberto, et al.
Publicado: (2021)